Newhouse, United Kingdom

David Jonathan Bennett


 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Newhouse, GB (2006 - 2013)
  • Edinburgh, GB (2005 - 2014)
  • West Point, PA (US) (2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Journey of David Jonathan Bennett

Introduction

David Jonathan Bennett is an influential inventor based in Newhouse, Great Britain. With a remarkable portfolio of 11 patents, Bennett has made significant contributions to the field of pharmaceuticals. His work primarily focuses on developing inhibitors and compounds that address various health issues, demonstrating a deep commitment to innovation in medicine.

Latest Patents

Among Bennett's latest patents is the invention related to 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives. This invention pertains to Cathepsin S inhibitors that hold promise for treating a range of diseases, including atherosclerosis, obesity, inflammation, immune disorders such as rheumatoid arthritis and psoriasis, as well as cancer and neuropathic pain. The formulation includes various substituents that interact effectively with the active site of Cathepsin S.

Another significant patent from Bennett is for (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives. This invention focuses on the development of pharmaceutical compositions aimed at treating atherosclerosis, showcasing his expertise in medicinal chemistry and drug formulation.

Career Highlights

Throughout his career, Bennett has collaborated with leading companies in the pharmaceutical industry, including MSD Oss B.V. and N.V. Organon. His work at these organizations has enabled him to leverage resources and expertise to develop groundbreaking medicinal solutions that have impactful applications in healthcare.

Collaborations

Bennett has worked alongside talented colleagues, including Jiaqiang Cai and Philip Stephen Jones. These collaborative efforts contribute to the innovative environment that shapes the development of new pharmaceutical compounds and therapies, allowing for a robust exchange of ideas and expertise.

Conclusion

David Jonathan Bennett exemplifies the spirit of innovation through his numerous patents and contributions to medical science. His focus on developing treatments for serious health conditions illustrates his commitment to improving lives through engineering and pharmaceutical advancements. As the fields of medicine and technology continue to evolve, Bennett's work will undoubtedly leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…